Dennis D Weisenburger

Summary

Affiliation: University of Nebraska Medical Center
Country: USA

Publications

  1. ncbi Does asbestos exposure cause non-Hodgkin's lymphoma or related hematolymphoid cancers? A review of the epidemiologic literature
    Dennis D Weisenburger
    Department of Pathology and Microbiology University of Nebraska Medical Center, Omaha, NE 68198, USA
    Clin Lymphoma 3:36-40. 2002
  2. ncbi Systemic anaplastic large-cell lymphoma: results from the non-Hodgkin's lymphoma classification project
    D D Weisenburger
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198 3135, USA
    Am J Hematol 67:172-8. 2001
  3. doi Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project
    Dennis D Weisenburger
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198 3135, USA
    Blood 117:3402-8. 2011
  4. ncbi Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group
    D D Weisenburger
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha 68198 3135, USA
    Am J Hematol 64:190-6. 2000
  5. pmc Cell of origin fails to predict survival in patients with diffuse large B-cell lymphoma treated with autologous hematopoietic stem cell transplantation
    Keni Gu
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198 3135, USA
    Hematol Oncol 30:143-9. 2012
  6. ncbi A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival
    Christine P Hans
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198 3135, USA
    Blood 101:2363-7. 2003
  7. doi Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma
    Kai Fu
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    J Clin Oncol 26:4587-94. 2008
  8. ncbi BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma
    Javeed Iqbal
    Leukemia Lymphoma Molecular Profiling Project, Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198 3135, USA
    J Clin Oncol 24:961-8. 2006
  9. pmc A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma
    Anamarija M Perry
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198 3135, USA
    Blood 120:2290-6. 2012
  10. ncbi Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group
    James Z Huang
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA
    Leuk Lymphoma 45:1551-7. 2004

Collaborators

Detail Information

Publications113 found, 100 shown here

  1. ncbi Does asbestos exposure cause non-Hodgkin's lymphoma or related hematolymphoid cancers? A review of the epidemiologic literature
    Dennis D Weisenburger
    Department of Pathology and Microbiology University of Nebraska Medical Center, Omaha, NE 68198, USA
    Clin Lymphoma 3:36-40. 2002
    ..Therefore, it can be concluded that there is no increased risk of NHL or other HL-CAs associated with asbestos exposure...
  2. ncbi Systemic anaplastic large-cell lymphoma: results from the non-Hodgkin's lymphoma classification project
    D D Weisenburger
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198 3135, USA
    Am J Hematol 67:172-8. 2001
    ..In contrast, patients with ALCL-B appear to be similar to those with other forms of DLBCL...
  3. doi Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project
    Dennis D Weisenburger
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198 3135, USA
    Blood 117:3402-8. 2011
    ..Thus, the IPI and a single pathologic feature could be used to stratify patients with PTCL-not otherwise specified for novel and risk-adapted therapies...
  4. ncbi Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group
    D D Weisenburger
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha 68198 3135, USA
    Am J Hematol 64:190-6. 2000
    ..We conclude that new therapeutic approaches, with the patients stratified by histologic type and clinical prognostic factors, are clearly needed for MCL...
  5. pmc Cell of origin fails to predict survival in patients with diffuse large B-cell lymphoma treated with autologous hematopoietic stem cell transplantation
    Keni Gu
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198 3135, USA
    Hematol Oncol 30:143-9. 2012
    ..However, no significant differences were found in the 5-year overall or event-free survivals using any of these approaches. In conclusion, cell of origin fails to predict survival of DLBCL patients treated with AHSCT...
  6. ncbi A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival
    Christine P Hans
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198 3135, USA
    Blood 101:2363-7. 2003
    ..However, patients with FL3 having a diffuse component of more than 50% have an inferior survival that is similar to the survival of those with DLBCL...
  7. doi Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma
    Kai Fu
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    J Clin Oncol 26:4587-94. 2008
    ..However, with the addition of rituximab to standard chemotherapy, the prognostic significance of this subclassification of DLBCL is unclear...
  8. ncbi BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma
    Javeed Iqbal
    Leukemia Lymphoma Molecular Profiling Project, Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198 3135, USA
    J Clin Oncol 24:961-8. 2006
    ..DLBCL is heterogeneous, and the expression of BCL2 is variable within the two major subgroups of DLBCL, germinal center B-cell-like (GCB) and activated B-cell-like (ABC) DLBCL, as well as primary mediastinal DLBCL...
  9. pmc A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma
    Anamarija M Perry
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198 3135, USA
    Blood 120:2290-6. 2012
    ..This new biologic prognostic model could be used with the International Prognostic Index to stratify patients for novel or risk-adapted therapies...
  10. ncbi Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group
    James Z Huang
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA
    Leuk Lymphoma 45:1551-7. 2004
    ..Our findings suggest that patients with DLBCL arising in NLPHL have a prognosis similar to those with de novo DLBCL and should be treated aggressively...
  11. pmc Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab
    Paul N Meyer
    University of Nebraska Medical Center, Omaha, NE 68198 3135, USA
    J Clin Oncol 29:200-7. 2011
    ..Various immunohistochemical algorithms have been developed to replicate these microarray results and/or stratify patients according to survival. This study compares some of those algorithms and also proposes some modifications...
  12. ncbi Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant hodgkin lymphoma. A report of 21 cases from the Nebraska Lymphoma Study Group
    James Z Huang
    Department of Pathology, University of Nebraska Medical Center, Omaha, NE, USA
    Leuk Lymphoma 44:1903-10. 2003
    ..In conclusion, our findings suggest that patients with DLBCL arising in NLPHL have a prognosis similar to those with de novo DLBCL and should be treated aggressively...
  13. doi The stromal cell marker SPARC predicts for survival in patients with diffuse large B-cell lymphoma treated with rituximab
    Paul N Meyer
    Dept of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, 68198, USA
    Am J Clin Pathol 135:54-61. 2011
    ..More aggressive chemotherapy protocols should be considered for patients with ABC DLBCL without SPARC+ stromal cells. CD68 expression by cells in the microenvironment did not predict survival...
  14. doi A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy
    William W L Choi
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198 3135, USA
    Clin Cancer Res 15:5494-502. 2009
    ..Since then, new antibodies specific to germinal center B-cells have been developed, which might improve the performance of an immunostain algorithm...
  15. pmc Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP
    Xin Huang
    Xin Huang, Bin Meng, Wenfeng Cao, and Kai Fu, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin Chengfeng Bi, West China Hospital, West China School of Medicine of Sichuan University, Chengdu, China Xin Huang, Bin Meng, Javeed Iqbal, Anamarija M Perry, Wenfeng Cao, Lynette M Smith, Chengfeng Bi, Chunsun Jiang, Timothy C Greiner, Dennis D Weisenburger, James O Armitage, Julie M Vose, Timothy W McKeithan, Wing C Chan, and Kai Fu, University of Nebraska Medical Center, Omaha, NE B Belinda Ding and B Hilda Ye, Albert Einstein College of Medicine, Bronx, NY Lisa Rimsza, University of Arizona, Tucson, AZ Andreas Rosenwald, University of Wurzburg, Department of Physiology and Biophysics
    J Clin Oncol 31:4520-8. 2013
    ..In this study, we investigated whether STAT3 activation can risk stratify patients with DLBCL...
  16. doi Phase II trial of 131-Iodine tositumomab with high-dose chemotherapy and autologous stem cell transplantation for relapsed diffuse large B cell lymphoma
    Julie M Vose
    Department of Internal Medicine, Division of Hematology Oncology, University of Nebraska Medical Center, Omaha, Nebraska 68198 7680, USA
    Biol Blood Marrow Transplant 19:123-8. 2013
    ..A follow-up phase III trial with 131-Iodine tositumomab/BEAM vs rituximab/BEAM was planned based on this information...
  17. ncbi CNOP for diffuse aggressive non-Hodgkin's lymphoma: the Nebraska lymphoma study group experience
    Julie M Vose
    Section of Hematology Oncology, University of Nebraska Medical Center, Nebraska Medical Center, Omaha 68198 7680, USA
    Leuk Lymphoma 43:799-804. 2002
    ..However, patients of all ages who failed CNOP and who were able to receive HDC and ASCT demonstrated long-term disease survival after the transplant...
  18. doi Late relapse in patients with diffuse large B-cell lymphoma
    Julie M Vose
    Department of Internal Medicine, Section of Hematology Oncology, University of Nebraska Medical Center, Omaha, NE, USA
    Br J Haematol 151:354-8. 2010
    ..A small percentage of the late relapsing patients can have a prolonged second remission. However, the overall survival from the time of relapse was not different between early and late relapsing patients with most succumbing to lymphoma...
  19. ncbi Optimized adoptive T-cell therapy for the treatment of residual mantle cell lymphoma
    Corey M Munger
    Department of Genetics, Cell Biology and Anatomy, Center for Research in Leukemia and Lymphoma, University of Nebraska Medical Center, Omaha, NE 68198 6395, USA
    Cancer Immunol Immunother 61:1819-32. 2012
    ..These results clearly show that MCL-specific cellular immunotherapy is effective in treating minimal residual MCL, paving the way for future clinical studies...
  20. doi Lymph node-induced immune tolerance in chronic lymphocytic leukaemia: a role for caveolin-1
    Christine E Gilling
    Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE 68198 6395, USA
    Br J Haematol 158:216-31. 2012
    ..Therefore, we report a novel role for CAV1 in tumour-induced immunosuppression during the progression of CLL...
  21. doi BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab
    Javeed Iqbal
    Departments of Pathology and Microbiology and Hematology Oncology and College of Public Health, Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE 68198, USA
    Clin Cancer Res 17:7785-95. 2011
    ..However, after the inclusion of rituximab (R) in the CHOP regimen, several conflicting observations about the prognostic value of BCL2 expression have been reported...
  22. pmc BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma
    Javeed Iqbal
    Department of Pathology and Microbiology, University of Nebraska Medical Center, 983135 Nebraska Medical Center, Omaha, NE 68198 3135, USA
    Am J Pathol 165:159-66. 2004
    ..However, despite this higher proliferative activity, there was no significant difference in overall or failure-free survival between the t(14;18)-positive and -negative subsets within the GCB subgroup...
  23. doi Cytogenetic abnormalities and clinical correlations in peripheral T-cell lymphoma
    Marilu Nelson
    Human Genetics Laboratories, Munroe Meyer Institute for Genetics and Rehabilitation, University of Nebraska Medical Center, Omaha, NE 68198 5440, USA
    Br J Haematol 141:461-9. 2008
    ..Although, genetic differences were noted in these subtypes, further studies are needed to determine the key pathogenetic events in PTCL...
  24. doi CD43 expression is associated with inferior survival in the non-germinal centre B-cell subgroup of diffuse large B-cell lymphoma
    Zdravko Mitrovic
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA
    Br J Haematol 162:87-92. 2013
    ..The dismal outcome of CD43(+) cases in the non-GCB subgroup may be explained, at least in part, by a less favourable microenvironment...
  25. doi B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma: study of 39 cases
    Anamarija M Perry
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA
    Br J Haematol 162:40-9. 2013
    ..This B-cell lymphoma is a morphologically-recognizable entity with a spectrum of genetic abnormalities. New and better treatments are needed for this aggressive lymphoma...
  26. ncbi Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic Index
    Julie M Vose
    Department of Preventive and Societal Medicine, University of Nebraska Medical Center, Omaha, Nebraska 68198 7680, USA
    Biol Blood Marrow Transplant 14:36-42. 2008
    ..These data suggest that transplantation earlier in the course of the disease for patients with follicular lymphoma with use of a monoclonal antibody-based regimen may lead to improved outcomes...
  27. doi Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma
    Ganapati V Hegde
    Department of Genetics, Cell Biology, and Anatomy, Center for Research in Leukemia and Lymphoma, University of Nebraska Medical Center, Omaha, NE 68198 6395, USA
    Mol Cancer Ther 7:1450-60. 2008
    ..Thus, our results indicate a significant role for Shh-GLI signaling in the proliferation of MCL, and molecular targeting of GLI is a potential therapeutic approach to improve the treatment for MCL...
  28. doi Does functional imaging distinguish nodular lymphocyte-predominant hodgkin lymphoma from T-cell/histiocyte-rich large B-cell lymphoma?
    Nicholas A Barber
    Department of Internal Medicine, Division of Hematology Oncology, University of Nebraska Medical Center, Omaha, Nebraska, USA
    Clin Lymphoma Myeloma Leuk 13:392-7. 2013
    ..Aggressive lymphomas are usually more PET avid than the indolent subtypes. Therefore, it is possible that PET/CT may help distinguish NLPHL from THR-LBCL...
  29. pmc Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma
    Timothy C Greiner
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198, USA
    Proc Natl Acad Sci U S A 103:2352-7. 2006
    ..This information on molecular phenotypes may provide new areas of investigation for ATM function or may be exploited by designing specific therapies for MCL cases with p53 aberrations...
  30. ncbi Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities
    Amit K Mittal
    Department of Genetics, University of Nebraska Medical Center, Omaha, NE 68198 6395, USA
    Int J Mol Med 20:461-9. 2007
    ....
  31. pmc MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma
    Cuiling Liu
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
    Blood 122:2083-92. 2013
    ..Of these, the miR-17∼92 cluster and its paralogues were also highly expressed in ALK(+) ALCL and may represent important downstream effectors of the ALK oncogenic pathway...
  32. ncbi Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma
    Christine P Hans
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198 3135, USA
    Mod Pathol 18:1377-84. 2005
    ..035). Cyclin D2 and PKC-beta expression will be useful in designing a 'biological prognostic index' for patients with DLBCL...
  33. pmc t(14;18)-negative follicular lymphomas are associated with a high frequency of BCL6 rearrangement at the alternative breakpoint region
    Keni Gu
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198 3135, USA
    Mod Pathol 22:1251-7. 2009
    ..Therefore, it is important to perform FISH analysis with ABR to determine possible involvement of BCL6 rearrangement in follicular lymphoma, especially in t(14;18)-negative cases...
  34. doi Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome
    Gabriel C Caponetti
    a Department of Pathology, Creighton University Medical Center, Omaha, NE, USA
    Leuk Lymphoma 56:3082-9. 2015
    ..However, patients with double/triple-hit DLBCL have a very poor outcome and should be treated with aggressive or novel therapies. ..
  35. pmc Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma
    Javeed Iqbal
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
    Blood 123:2915-23. 2014
    ..05). In AITL, high expression of several signatures associated with the tumor microenvironment was significantly associated with outcome. A combined prognostic score was predictive of survival in an independent cohort (P = .004). ..
  36. pmc Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis
    Javeed Iqbal
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198 3135, USA
    Blood 119:4939-48. 2012
    ..The other clusters showed enrichment of stroma-associated miRNAs, and also had higher expression of stroma-associated genes. Our clinical outcome analysis in the present study suggested that miRNAs can serve as prognosticators...
  37. pmc Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma
    Javeed Iqbal
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198 3135, USA
    Blood 115:1026-36. 2010
    ..Oncogenic pathways and tumor-host interactions also were identified, and these findings may lead to better therapies and outcome in the future...
  38. ncbi Cytogenetics and fluorescence in situ hybridization studies of diffuse large B-cell lymphoma in children and young adults
    Bhavana J Dave
    Human Genetics Laboratory, Munroe Meyer Institute for Genetics and Rehabilitation, 985440 Nebraska Medical Center, Omaha, NE 68198 5440, USA
    Cancer Genet Cytogenet 153:115-21. 2004
    ..The t(8;14)(q24;q32) with rearranged CMYC ascertained by FISH, was observed in a single young adult DLBCL case. These results highlight a distinctly different representation of cytogenetic abnormalities in pediatric versus adult DLBCL...
  39. pmc Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma
    Alyssa Bouska
    Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
    Blood 123:1681-90. 2014
    ..2-24.1 or 6q13-15, predicted overall survival. Abnormalities associated with transformation of the disease likely impair immune surveillance, activate the nuclear factor-κB pathway, and deregulate p53 and B-cell transcription factors. ..
  40. doi Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target
    Ganapati V Hegde
    Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE 68198 6395, USA
    Mol Cancer Res 6:1928-36. 2008
    ..Together, these results reveal that Hh signaling is important in the pathogenesis of B-CLL and, hence, may be a potential therapeutic target...
  41. pmc Survival disparities in patients with lymphoma according to place of residence and treatment provider: a population-based study
    Fausto R Loberiza
    Section of Oncology Hematology, Summer Undergraduate Research Program, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    J Clin Oncol 27:5376-82. 2009
    ....
  42. pmc Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma
    Ken H Young
    Department of Pathology and Microbiology, Munroe Meyer Institute for Genetics and Rehabilitation, Omaha, NE, USA
    Blood 110:4396-405. 2007
    ..Investigation is warranted into targeted therapy toward TRAIL receptor-2, to potentially bypass the adverse effect of mutated TP53 in DLBCL...
  43. ncbi Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma
    Patricia Aoun
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198 3135, USA
    Leuk Lymphoma 45:1595-603. 2004
    ..Interphase FISH studies improve the cytogenetic diagnosis when performed in conjunction with karyotyping in B-CLL/SLL, but the prognostic relevance of various abnormalities could not be confirmed in this study...
  44. doi Lymphoma diagnosis at an academic centre: rate of revision and impact on patient care
    Joslin M Bowen
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA
    Br J Haematol 166:202-8. 2014
    ..Mandatory review of outside pathology material prior to treatment of patients for lymphoma will identify a significant number of misclassified cases with a major change in therapy. ..
  45. pmc Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling
    Kai Fu
    Department of Pathology and Microbiology, University of Nebraska Medical Center, 983135 Nebraska Medical Center, Omaha, NE 68198 3135, USA
    Blood 106:4315-21. 2005
    ..In conclusion, cases of cyclin D1-negative MCL do exist and are part of the spectrum of MCL. Up-regulation of cyclin D2 or D3 may substitute for cyclin D1 in the pathogenesis of MCL...
  46. doi Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases
    Javier A Laurini
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA
    Blood 120:4795-801. 2012
    ..0001). Our study provides new objective evidence that the distribution of NHL subtypes varies significantly by geographic region and should prompt epidemiologic studies to explain these differences...
  47. doi Novel therapy for therapy-resistant mantle cell lymphoma: multipronged approach with targeting of hedgehog signaling
    Ganapati V Hegde
    Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE 68198 6395, USA
    Int J Cancer 131:2951-60. 2012
    ....
  48. ncbi The t(14;18) and bcl-2 expression are present in a subset of primary cutaneous follicular lymphoma: association with lower grade
    Lyle C Lawnicki
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha 68198 3135, USA
    Am J Clin Pathol 118:765-72. 2002
    ..We conclude that bcl-2 protein expression and the t(14;18) are present in a subset of PCFL, particularly in lower grade cases...
  49. pmc Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphoma
    Nilesh W Gaikwad
    Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198 6805, USA
    Biomarkers 14:502-12. 2009
    ..Thus, formation of estrogen-DNA adducts may play a critical role in the aetiology of NHL, and these adducts could be potential biomarkers of NHL risk...
  50. ncbi Modulation of p73 isoforms expression induces anti-proliferative and pro-apoptotic activity in mantle cell lymphoma independent of p53 status
    Hesham M Hassan
    a Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA
    Leuk Lymphoma 57:2874-2889. 2016
    ..These studies demonstrate the potential for diclofenac as novel therapeutic agent in MCL independent of p53 status...
  51. doi Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling
    Ji Yuan
    Department of Pathology and Microbiology Department of Biostatistics, College of Public Health Department of Hematology Oncology, University of Nebraska Medical Center, Omaha, NE Metabolism Branch Laboratory of Pathology, Center for Cancer Research, NCI, NIH, Bethesda, MD Department of Pathology, City of Hope National Medical Center, Duarte, CA Department of Pathology, University of Arizona, Tucson, AZ Department of Clinical Pathology, Oregon Health and Science University, Portland, OR Department of Molecular Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, OH Institute of Pathology, Comprehensive Cancer Center Mainfranken, University of Wurzburg, Würzburg Department of Clinical Pathology, Robert Bosch Krankenhaus, Dr Margarete Fischer Bosch Institute of Clinical Pharmacology, Stuttgart, Germany British Columbia Cancer Agency, Centre for Lymphoid Cancer, University of British Columbia, Vancouver, BC, Canada Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain Department of Pathology, The Norwegian Radium Hospital, University of Oslo, Oslo, Norway
    Am J Surg Pathol 39:1322-30. 2015
    ..In conclusion, PMBL can present as a nonmediastinal tumor without evidence of mediastinal involvement, and GEP offers a more precise diagnosis of PMBL. ..
  52. ncbi Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
    Christine P Hans
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198, USA
    Blood 103:275-82. 2004
    ..0001). In summary, immunostains can be used to determine the GCB and non-GCB subtypes of DLBCL and predict survival similar to the cDNA microarray...
  53. ncbi Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual disease
    Julie M Vose
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 69198, USA
    J Clin Oncol 20:2344-52. 2002
    ....
  54. ncbi Hereditary chronic lymphocytic leukemia: an extended family study and literature review
    Henry T Lynch
    Department of Preventive Medicine and Public Health at Creighton University School of Medicine, Omaha, NE 68178, USA
    Am J Med Genet 115:113-7. 2002
    ..Given the explosive developments in molecular genetics during the past decade, it is certain that families of this type will provide important clues to the etiology, pathogenesis, and ultimate prevention of CLL...
  55. pmc IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma
    Chao Wang
    Shandong University School of Medicine, Jinan, People s Republic of China China Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE Department of Pathology, City of Hope National Medical Center, Duarte, CA
    Blood 126:1741-52. 2015
    ..Integrative analysis of gene expression and promoter methylation revealed recurrently hypermethylated genes involved in T-cell receptor signaling and T-cell differentiation that likely contribute to lymphomagenesis in AITL. ..
  56. ncbi Familial B-cell chronic lymphocytic leukemia: analysis of cytogenetic abnormalities, immunophenotypic profiles, and immunoglobulin heavy chain gene usage
    Patricia Aoun
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198 3135, USA
    Am J Clin Pathol 127:31-8. 2007
    ..Our findings support previous observations that familial and sporadic B-CLL cases are biologically similar and suggest that familial clusters will be useful for studying pathogenetic events in B-CLL...
  57. pmc Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling
    Karen E Deffenbacher
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, 68198 3135, USA
    Blood 119:3757-66. 2012
    ..Elucidation of the underlying target genes may provide insight into factors that modulate outcome and could provide potential novel therapeutic targets with less toxicity for pediatric patients with B-cell non-Hodgkin lymphoma...
  58. ncbi Family with acute myelocytic leukemia, breast, ovarian, and gastrointestinal cancer
    Henry T Lynch
    Department of Preventive Medicine and Public Health, Creighton University School of Medicine, 2500 California Plaza, Omaha, NE 68178, USA
    Cancer Genet Cytogenet 137:8-14. 2002
    ..However, two family members affected with AML exhibited abnormal acquired clones in their bone marrow specimens by both G-band studies and interphase FISH, both with a deletion of 5q...
  59. ncbi Prognostic factors influencing survival in patients with B-cell small lymphocytic lymphoma
    Marin Nola
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA
    Am J Hematol 77:31-5. 2004
    ..In multivariate analysis, the IPI score was the only significant predictor of OS. Anemia and B symptoms were additionally predictive of poor OS in patients with low IPI scores...
  60. ncbi The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile
    James Z Huang
    Department of Pathology, The Munroe Meyer Institute for Genetics and Rehabilitation, University of Nebraska Medical Center, Omaha, NE 68198, USA
    Blood 99:2285-90. 2002
    ..CD10 protein expression is useful in identifying cases of DLBCL with a germinal center B-cell gene expression profile and is often expressed in cases with the t(14;18)...
  61. doi Classification of non-Hodgkin lymphomas in Guatemala according to the World Health Organization system
    Anamarija M Perry
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198 3135, USA
    Leuk Lymphoma 52:1681-8. 2011
    ..However, there is no significant difference in the frequency of the DLBCL subtypes compared to North America and Europe...
  62. pmc Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project
    Massimo Federico
    Universita di Modena e Reggio Emilia, Modena, Italy
    J Clin Oncol 31:240-6. 2013
    ..The International Peripheral T-Cell Lymphoma Project was undertaken to better understand the subtypes of T-cell and natural killer (NK) -cell lymphomas...
  63. doi Mantle cell lymphoma with flow cytometric evidence of clonal plasmacytic differentiation: a case report
    Hina Naushad
    Department of Pathology and Microbiology, University of Nebraska Medical Center, 983135 Nebraska Medical Center, Omaha, NE 68198 3135, USA
    Cytometry B Clin Cytom 76:218-24. 2009
    ..However, no flow cytometric studies that demonstrate plasmacytic (PC) differentiation in MCL have been reported. Herein, we report a case of MCL with PC differentiation identified by flow cytometry...
  64. ncbi Autologous hematopoietic stem cell transplantation for mantle cell lymphoma
    J M Vose
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha 68198 7680, USA
    Biol Blood Marrow Transplant 6:640-5. 2000
    ..Whether this therapy will increase the overall survival or EFS in patients receiving transplants in first complete remission will need to be tested in prospective randomized clinical trials...
  65. ncbi High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma
    Z S Pavletic
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha, USA
    Ann Oncol 9:1023-6. 1998
    ..However, the long-term utility of this therapy for B-CLL is unknown...
  66. ncbi Effect of follicularity on autologous transplantation for large-cell non-Hodgkin's lymphoma
    J M Vose
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha 69198 3332, USA
    J Clin Oncol 16:844-9. 1998
    ....
  67. pmc Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease
    Amit K Mittal
    Department of Genetics, Cell Biology, and Anatomy, University of Nebraska Medical Center, Omaha, Nebraska, United States of America
    Mol Med 20:290-301. 2014
    ..Together, our findings demonstrate that the lymphoid microenvironment promotes survival, proliferation and progression of CLL cells via chronic activation of BCR, BAFF/APRIL and NF-κB activation while suppressing the immune response. ..
  68. doi Relationship between Rosai-Dorfman disease and IgG4-related disease: study of 32 cases
    Liping Liu
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA
    Am J Clin Pathol 140:395-402. 2013
    ..To assess the association between Rosai-Dorfman disease (RDD) and IgG4-related disease (IgG4-RD)...
  69. doi The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: a study of 826 cases from the International Peripheral T-cell Lymphoma Project
    Zdravko Mitrovic
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, 68198 3135, USA
    Am J Hematol 87:790-4. 2012
    ..In this study, lymphopenia was identified as a new adverse prognostic factor in the lymphoma type of ATLL...
  70. doi Racial patterns of extranodal natural killer/T-cell lymphoma, nasal type, in California: a population-based study
    Weiyun Z Ai
    Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA
    Br J Haematol 156:626-32. 2012
    ..In conclusion, ENKTL is more common and clinically more similar among Hispanics and APIs than non-Hispanic whites with poor outcome in all racial groups...
  71. pmc Genetic counseling for DAPK1 mutation in a chronic lymphocytic leukemia family
    Henry T Lynch
    Department of Preventive Medicine and Public Health, Creighton University School of Medicine, 2500 California Plaza, Omaha, NE 68178, USA
    Cancer Genet Cytogenet 186:95-102. 2008
    ..Their intellectual and emotional reaction to its presence or absence in them was assessed. This family serves as a model for genetic counseling in disorders for which lifesaving intervention is not yet possible...
  72. ncbi Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group Experience
    A K Ganti
    Department of Internal Medicine, Division of Oncology Hematology, University of Nebraska Medical Center, Omaha, USA
    Ann Oncol 17:920-7. 2006
    ....
  73. ncbi Alcohol consumption, family history of hematolymphoproliferative cancer, and the risk of non-Hodgkin's lymphoma in men
    Brian C H Chiu
    Department of Preventive and Societal Medicine, University of Nebraska Medical Center, Omaha, NE 68198 4350, USA
    Ann Epidemiol 12:309-15. 2002
    ..To investigate the association between alcohol consumption and the risk of non-Hodgkin's lymphoma (NHL) and to examine whether the association is modified by a family history of hematolymphoproliferative cancer (HLPC)...
  74. doi Recurrent bone marrow aplasia secondary to nilotinib in a patient with chronic myeloid leukemia: a case report
    Prathima Prodduturi
    Department of Hematology Oncology, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    J Oncol Pharm Pract 18:440-4. 2012
    ..Possible mechanisms for this significant adverse drug reaction are discussed along with a review of literature...
  75. doi Immunohistochemical and molecular cytogenetic evaluation of potential targets for tyrosine kinase inhibitors in Langerhans cell histiocytosis
    Gabriel C Caponetti
    Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198, USA
    Hum Pathol 43:2223-8. 2012
    ..Clinical trials that evaluate the use of tyrosine kinase inhibitors in Langerhans cell histiocytosis seem warranted and should evaluate these markers...
  76. ncbi Clinical significance of hematologic parameters in non-Hodgkin's lymphoma at diagnosis
    M G Conlan
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha
    Cancer 67:1389-95. 1991
    ..These data suggest that hematologic evaluation at the time of diagnostic staging of NHL provides useful prognostic information that may have therapeutic implications...
  77. ncbi Ortho-quinones of benzene and estrogens induce hyperproliferation of human peripheral blood mononuclear cells
    Dhrubajyoti Chakravarti
    Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA
    Leuk Lymphoma 47:2635-44. 2006
    ..Thus, DNA damage induced by the ortho-quinones of benzene and estradiol may promote the growth of human blood mononuclear cells, including those that appear in large numbers in leukemia and lymphoma...
  78. ncbi Cytogenetic characterization of diffuse large cell lymphoma using multi-color fluorescence in situ hybridization
    Bhavana J Dave
    Human Genetics Laboratories, Munroe Meyer Institute for Genetics and Rehabilitation, University of Nebraska Medical Center, 985440 Nebraska Medical Center, Omaha, NE, USA
    Cancer Genet Cytogenet 132:125-32. 2002
    ..Overall, M-FISH has enhanced our ability to provide a comprehensive karyotypic analysis, and has helped in defining the importance of BCL3, BCL8, BCL9, and BCL10 carrying breakpoints in DLBCL...
  79. ncbi Hodgkin's disease in the elderly: improved treatment outcome with a doxorubicin-containing regimen
    Colin D Weekes
    University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    J Clin Oncol 20:1087-93. 2002
    ..Because of an improved side-effect profile, the regimen of chlorambucil, vinblastine, procarbazine, and prednisone (ChlVPP) has been proposed for use in elderly patients...
  80. ncbi The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
    Andreas Rosenwald
    Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    N Engl J Med 346:1937-47. 2002
    ..The survival of patients with diffuse large-B-cell lymphoma after chemotherapy is influenced by molecular features of the tumors. We used the gene-expression profiles of these lymphomas to develop a molecular predictor of survival...
  81. ncbi Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
    Sandeep S Dave
    National Cancer Institute, NIH, Bethesda, MD 20892, USA
    N Engl J Med 351:2159-69. 2004
    ..We used gene-expression profiles of tumor-biopsy specimens obtained at diagnosis to develop a molecular predictor of the length of survival...
  82. ncbi Cigarette smoking, familial hematopoietic cancer, hair dye use, and risk of t(14;18)-defined subtypes of non-Hodgkin's lymphoma
    Brian C H Chiu
    Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, 680 North Lake Shore Drive, Chicago, IL 60611, USA
    Am J Epidemiol 165:652-9. 2007
    ..Hair dye use was not associated with either subtype. These findings should be interpreted cautiously because of the small sample...
  83. ncbi Mantle cell lymphoma with plasma cell differentiation
    Ken H Young
    Department of Pathology and Laboratory Medicine, University of Wisconsin Hospital and Clinics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
    Am J Surg Pathol 30:954-61. 2006
    ..These findings indicate that the clonal PC differentiation may occur within GCs in some cases of MCL...
  84. ncbi A chromosomal translocation in cyclin D1-negative/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus
    Stefan Gesk
    Blood 108:1109-10. 2006
  85. ncbi Molecular diagnosis of Burkitt's lymphoma
    Sandeep S Dave
    National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    N Engl J Med 354:2431-42. 2006
    ..We examined whether gene-expression profiling could reliably distinguish Burkitt's lymphoma from diffuse large-B-cell lymphoma...
  86. pmc Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma
    Andreas Rosenwald
    Metabolism Branch, National Cancer Institute, National Institute of Health, Bethesda, MD 20892, USA
    J Exp Med 198:851-62. 2003
    ..The molecular diagnosis of PMBL should significantly aid in the development of therapies tailored to this clinically and pathogenetically distinctive subgroup of DLBCL...
  87. pmc Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
    Georg Lenz
    Metabolism Branch, Biometric Research Branch, Center for Information Technology, and Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA
    Proc Natl Acad Sci U S A 105:13520-5. 2008
    ..Together, these data provide genetic evidence that the DLBCL subtypes are distinct diseases that use different oncogenic pathways...
  88. pmc Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction
    Silvia Bea
    Department of Pathology and Hematology Hospital Clinic, University of Barcelona, Spain
    Blood 106:3183-90. 2005
    ..In addition, gains involving the chromosomal region 3p11-p12 provided prognostic information that was statistically independent of the previously defined gene-expression-based survival model, thereby improving its predictive power...
  89. ncbi Agricultural pesticide use, familial cancer, and risk of non-Hodgkin lymphoma
    Brian C H Chiu
    Department of Preventive Medicine and The Robert H Lurie Comprehensive Cancer Center, Northwestern University Medical School, 680 North Lake Shore Drive, Suite 1102, Chicago, IL 60611 4402, USA
    Cancer Epidemiol Biomarkers Prev 13:525-31. 2004
    ....
  90. pmc Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma
    Nicole Y Fang
    Genome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Proc Natl Acad Sci U S A 100:5372-7. 2003
    ..mutated ATM in MCL. Additional mutational and functional analyses are needed to determine whether ATM mutations contribute to the development and progression of MCL or are just the consequence of genomic instability in MCL...
  91. pmc Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature
    Itziar Salaverria
    Department of Pathology and Hematology, Hospital Clinic, University of Barcelona, Barcelona, Spain
    J Clin Oncol 25:1216-22. 2007
    ....
  92. pmc Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival
    Adrian Wiestner
    Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892, USA
    Blood 109:4599-606. 2007
    ..We conclude that alterations of CCND1 3'UTR structure can significantly increase its oncogenic effect and worsen the clinical course of MCL patients...
  93. ncbi The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
    Andreas Rosenwald
    The Lymphoma Leukemia Molecular Profiling Project, National Cancer Institute NIH, Bethesda, MD, USA
    Cancer Cell 3:185-97. 2003
    ..We propose a quantitative model of the aberrant cell cycle regulation in MCL that provides a rationale for the design of cell cycle inhibitor therapy in this malignancy...
  94. ncbi Outcome of autologous transplantation for mantle cell lymphoma: a study by the European Blood and Bone Marrow Transplant and Autologous Blood and Marrow Transplant Registries
    Elisabeth Vandenberghe
    Department of Haematology, St James Hospital, Dublin, Ireland
    Br J Haematol 120:793-800. 2003
    ..99 times (95% CI: 1.66-5.38, P < 0.001) more likely to die than patients transplanted in CR1. Autologous transplantation probably improves survival in patients with MCL especially if performed in first CR...
  95. pmc Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study
    Ken H Young
    Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, University of of Wisconsin Paul P Carbone Comprehensive Cancer Center, Madison, USA
    Blood 112:3088-98. 2008
    ..This study shows the prognostic importance of mutations in the TP53 DNA-binding domains in patients with DLBCL...
  96. ncbi Similar patterns of genomic alterations characterize primary mediastinal large-B-cell lymphoma and diffuse large-B-cell lymphoma
    Nallasivam Palanisamy
    Laboratory of Cancer Genetics, Cell Biology Program, Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Genes Chromosomes Cancer 33:114-22. 2002
    ..Based on these data, we conclude that PMLBCL is a distinct entity among GC-derived high-grade DLBCLs...
  97. ncbi Occupation and risk of non-Hodgkin's lymphoma and chronic lymphocytic leukemia
    Tongzhang Zheng
    Division of Environmental Health Science, Yale University School of Public Health, New Haven, CT, USA
    J Occup Environ Med 44:469-74. 2002
    ..These data suggest that the workers employed in these industries or occupations experienced an increased risk of NHL and CLL, and the risks associated with these industries or occupations may vary by histological type of NHL...
  98. ncbi An update of the epidemiology of non-Hodgkin's lymphoma
    Brian C H Chiu
    Department of Preventive Medicine, Northwestern University Medical School, and Robert H Lurie Comprehensive Cancer Center, Chicago, IL, USA
    Clin Lymphoma 4:161-8. 2003
    ..Evaluation of polymorphisms in genes involved in immune function, inflammation, and the activation or detoxification of environmental and occupational chemicals is also warranted...
  99. ncbi Nutrient intakes and adenocarcinoma of the esophagus and distal stomach
    Honglei Chen
    Human Nutrition Research Center on Aging, Tufts University, Boston, MA 02111, USA
    Nutr Cancer 42:33-40. 2002
    ....
  100. ncbi Diet and risk of adult glioma in eastern Nebraska, United States
    Honglei Chen
    Tufts University, Human Nutrition Research Center on Aging, Boston, MA, USA
    Cancer Causes Control 13:647-55. 2002
    ..To investigate potential associations between diet and adult glioma...
  101. ncbi Hair dyes and risk of glioma among Nebraska women
    Ellen F Heineman
    Division of Cancer Epidemiology and Genetics, NIH, DHHS, National Cancer Institute, Bethesda, MD 20892 7242, USA
    Cancer Causes Control 16:857-64. 2005
    ..These suggestive findings need confirmation in future studies with larger sample sizes, fewer proxy respondents, and the ability to evaluate the effect of changes in formulations over time...